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infection were commonly associated with severe illness. In contrast, corticosteroid administration was
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in the severely medically ill cancer population has been characterized by an increased disturbance of
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ABSTRACT
Objective: Our aim was to examine the characteristics of delirium in the severely medically ill
cancer population on the basis of sociodemographic and medical variables, delirium severity,
and phenomenology, as well as severity of medical illness.
Method: All subjects in the database were recruited from psychiatric referrals at Memorial
Sloan Kettering Cancer Center (MSKCC). Sociodemographic and medical variables, as well as
the Karnofsky Performance Status (KPS) scale and Memorial Delirium Assessment Scale
(MDAS) scores were recorded at baseline. Subsequently, these variables were analyzed with
respect to the severity of the medical illness.
Results: Out of 111 patients, 67 qualified as severely medically ill. KPS scores were 19.7 and
30.7 in less severe illness. There were no significant differences with respect to age, history of
dementia, and MDAS scores. Although the severity of delirium did not differ, an increased
frequency and severity of consciousness disturbance, disorientation, and inability to maintain
and shift attention did exist. With respect to etiologies contributing to delirium, hypoxia and
infection were commonly associated with severe illness. In contrast, corticosteroid
administration was more often associated with less severe illness. There were no differences
with respect to opiate administration, dehydration, and CNS disease, including brain
metastasis.
Significance of Results: Delirium in the severely medically ill cancer population has been
characterized by an increased disturbance of consciousness, disorientation, and an inability to
maintain and shift attention. However, the severity of illness did not predict severity of
delirium. Furthermore, hypoxia and infection were etiologies more commonly associated with
delirium in severe illness, whereas the administration of corticosteroidswas associatedwith less
severe illness.
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INTRODUCTION
Delirium is a neuropsychiatric disorder character-
ized by disturbances of consciousness, cognition,
and perception. The syndrome has an abrupt onset,
fluctuating course, and a contributing physiological
etiology. Further characteristic symptoms include
affective changes and psychomotor abnormalities,
as well as sleep–wake cycle disturbances (Trzepacz
et al., 1999).
The occurrence rate of delirium depends on the
age of the patient and the severity of the illness
(Francis et al., 1990; Voyer et al., 2007). In the gene-
ral hospital setting, the occurrence of delirium in
medically ill patients ranges between 15 and 30%,
in the hospitalized elderly between 10 and 40%
(Bucht et al., 1999; Lipowski, 1989), and in cancer
patients from 57 to 85%. Among terminally ill pa-
tients, the incidence of delirium can reach 85%
(Bond et al., 2006; Breitbart & Strout, 2000; Massie
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et al., 1983). In particular in the elderly, the preva-
lence and incidence of delirium remain high. Some
14 to 24% of elderly patients may be delirious at the
time of admission, and 6 to 56% will go on to develop
delirium during their course of hospitalization. Fur-
thermore, delirium is associated with poor functional
outcome, increasedmorbidity andmortality, and pro-
longed hospitalization (Inouye, 1998).
Several risk factors for delirium have been identi-
fied. These include advanced age, cognitive impair-
ment, low albumin level, bone metastases, and the
presence of hematological malignancy (Ljubisavljevic
&Kelly, 2003).Medications have been identified as an-
other risk factor contributing to delirium—including
benzodiazepines, corticosteroids, and opioids (Gau-
dreau et al., 2005). The reversibility and irreversibility
of deliriumhave constituted another topic of investiga-
tion. Opioids and dehydration have been associated
with reversible delirium, while hypoxic encephalopa-
thy and infection have been identified as factors con-
tributing to irreversible delirium (Lawlor et al.,
2000a).
In patients with advanced cancer, delirium is usu-
ally a multifactorial syndrome. Among this popula-
tion, opiates factor into almost 60% of episodes and
represent the most frequent etiology (Centeno
et al., 2004). In terminal cancer, opiates have been as-
sociated with incidence of delirium. In 50% of
delirium cases, however, significant symptom im-
provement can be achieved, deeming delirium as a
serious and frequent complication in terminal cancer
with an outcome not as poor as previously believed
(Gagnon et al., 2000).
Although a number of studies have sought to in-
vestigate the factors contributing to delirium, the
characteristics of delirium in the severely medically
ill cancer population remain understudied. Etiologi-
cal factors in this population have been partly inves-
tigated, but the characteristics of delirium in this
population remain unknown.
To date, there have been no studies of delirium
severity and phenomenology among patients with se-
vere medical illness. A secondary analysis of existing
datawas performed with respect to severely medical-
ly ill patients in order to identify the factors related to
delirium associated with this population.
METHODS
Subjects
Subjects in our trial included patients referred for de-
lirium management to the Memorial Sloan Kettering
Cancer Center (MSKCC) psychiatry service from
July of 2004 to June of 2006. Sloan Kettering is a
470-bed, private hospital specializing in the treatment
of cancer, averaging more than 20,000 admissions per
year. The consultation-liaison psychiatry service per-
forms on averagemore than 2,000 consultationsyearly.
All patients included in our study were managed
for delirium andmet the criteria for a diagnosis of de-
lirium according to the Diagnostic and Statistical
Manual of Mental Disorders, 4th ed. (DSM–IV–TR)
(American Psychiatric Association, 2000). The exclu-
sion criteria includedan inability to complywithdelir-
ium assessment and objections to assessment or
management of delirium with antipsychotics on the
part of the patient or their family.
Consent was obtained from all capable patients
who participated in the study. In patients with a lim-
ited capacity to provide consent due to delirium, the
primary caregiver provided verbal consent alongside
the patient’s assent to intervention.
All data were obtained from the routine care of pa-
tients, recorded in an MSKCC psychiatry service clin-
ical database approved by the institutional review
board, and awaiverwas obtained for the data analysis.
Measurements
The following information was collected for the base-
line assessment: age, sex, cancer diagnosis, stage of
cancer (localized, metastatic, or terminal), psychiat-
ric diagnoses including a history of dementia, pres-
ence of brain metastases, and delirium etiology. The
level of functioning was assessed with the Karnofsky
Performance Status (KPS) scale, indicating physical
performance ability (Karnofsky & Burchenal, 1949).
This scale was developed particularly for the cancer
population, and scores range from 10 to 100. Scores
less than 50 indicate an inability to care for oneself,
requiring hospital care; a score of 40 indicates a
disability with a need for assistance; a score of 30
indicates a severe disability requiring hospital ad-
mission; a score of 20 indicates a need for hospital ad-
mission and active treatment of a very sick patient;
and a score of 10 indicates a moribund state.
Delirium severity was measured with the MDAS,
a 10-item, 4-point clinician-rated scale (possible
range 0–30) (Breitbart et al., 1997). MDAS items
range from 0 (absent), to 1 (mild), 2 (moderate), and
3 (severe) in presentation. This instrument provides
a clear description of the severity and presence of
symptoms. Scale items assess disturbance in arousal
and level of consciousness as well as several areas of
cognitive functioning, in psychomotor activity, and in
the sleep–wake cycle. AnMDAS score above 10 iden-
tifies the presence of delirium (Lawlor et al., 2000b).
Statistical Analysis
Analyses were performed with the Statistical Pack-
age for the Social Sciences (SPSS, v. 20) for Windows.
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For the purpose of our analysis, severity of medical
illness was defined as a dichotomous variable with
two levels: KPS , 30, representing the severely med-
ically ill cancer population, and KPS  30, repre-
senting the less severely ill. Descriptive statistics
were computed in order to assess sociodemographic
and medical variables, and MDAS scores and sub-
scores. In respect to delirium severity, mean MDAS
scores were employed, andwith respect to prevalence
of single delirium symptoms, moderate and severe
symptomatology.
Data on the interval scale such as age were com-
puted with a t test, data on the ordinal or categorical
scale (such as delirium severity or prevalence of etiol-
ogies) with the Mann–Whitney U test for pairwise
comparison of independent samples, and data on
the categorical scale with Pearson’s chi-square test
(x2). Post hoc, for all implemented tests, Cronbach’s
a was adjusted using the Bonferroni method. The
significance level of a was set at p , 0.05.
RESULTS
Baseline Characteristics
Some 67 of 111 patients had a KPS score less than 30
(60.4%) and had severe medical illness, in contrast to
44 patients with a KPS score greater than 30 (39.6%)
with less severe illness.
Therewere no differences in age, in presence of de-
mentia or brain metastasis, or in stage of illness be-
tween severe and less severe (see Table 1). With
respect to cancer diagnoses, the prevalence of brain
cancer and gastrointestinal cancer differed between
severe and less severe illness. Brain cancer was
more frequently found in the less severely ill, where-
as gastrointestinal cancer was more often found in
the severely ill. There were no differences in preva-
lence of hypoactive versus hyperactive delirium;
hypoactive delirium occurred in 49.3% in severe ill-
ness and 38.6% in less severe illness. Hyperactive de-
lirium, in contrast, occurred in 50.7 and 61.4%,
respectively.
Delirium Severity and Phenomenology
The MDAS scores at baseline were not different
(Table 1). The severely ill had a baseline MDAS score
of 18.8 and the less severely ill 17.4. However, there
were differences in severity of disturbances of con-
sciousness, orientation, and ability to maintain and
shift attention (Table 2). In the severely ill cancer
population, disturbance of consciousness was more
pronounced (2.04 vs. 1.77), as were disorientation
(2.19 vs. 1.89) and inability to shift and maintain at-
tention (2.07 vs. 1.80). No differences were noted in
the cognitive domain, perceptual disturbances and
delusions, psychomotor abnormality, or sleep–wake
cycle disturbances.
In addition to the different degrees of symptomato-
logical severity, differences in frequency of moderate
and severe symptoms existed between both groups.
Some 94% of the severely ill had a disturbance of con-
sciousness compared to 77% of the less severely ill.
Disorientation was present in 87% compared to
66%, respectively. In contrast to the severity of symp-
toms represented by mean MDAS scores, the diffe-
rence with respect to ability to maintain and shift
attention did not reach statistical significance
( p ¼ 0.052)
Etiologies Contributing to Delirium
The etiological factors contributing to delirium in se-
vere medical illness were hypoxia and infection. In
severe medical illness, hypoxia was present in
44.8% compared to 25.0% in less severe illness; infec-
tion was present in 34.3 and 9.1%, respectively. In
contrast, the administration of corticosteroids was
associatedwith higher KPS scores, indicating less se-
vere illness or a protective effect of corticosteroid ad-
ministration. Almost two thirds of the less severely ill
(61.4%) received corticosteroids in contrast to one
third (37.4%) of the severely ill. Other etiological fac-
tors did not reveal differences between severities of
illness. The administration of opiates, the presence
of CNS disease, dehydration, and the administration
of other medications were comparable.
Severity if Illness and Functional Status
The severity of illness and level of functioning were
different between groups as set by the design. The
mean KPS scores in severe medical illness were
19.7 and 30.7.
DISCUSSION
In this sample of 111 patients with delirium, the over-
all delirium severity among severely medically ill
cancer patients was not significantly different from
less ill patients. However, impairment within the in-
dividual domains of consciousness, orientation, and
ability to shift and maintain attention was more se-
vere. The etiological factors contributing to more se-
vere medical illness were hypoxia and infection. In
contrast, the administration of corticosteroids was
more frequently observed in less severely ill patients.
Surprisingly, severe medical illness was not asso-
ciated with a higher MDAS score, suggesting that
severity of medical illness does not necessarily predict
severity of delirium. However, severity of medical ill-
ness was associated with an increased frequency,
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severity, and level of disturbances of consciousness
anddisorientation.With respect to attentional impair-
ment, only the difference in severity reached statisti-
cal significance. Thus, these findings represent new
insights into the phenomenology of delirium in severe
medical illness.
Previously, hypoxia and infection were identified
as causes of irreversible delirium (Lawlor et al.,
2000a). Due to the length of the observation period,
no definite statement about reversibility could be
made in our study, but, similarly, hypoxia and infec-
tionmore frequently contributed tomore severemed-
ical illness. Although corticosteroids themselves
represent a risk factor for delirium (Ljubisavljevic
& Kelly, 2003), corticosteroids were more often
associated with less severe illness in our study, and
it appeared that corticosteroids may have a benefi-
cial, protective effect on severity of illness.
The relevance of opiate administration contribut-
ing to deliriumwas higher than previously indicated.
Compared to approximately 60% of opiate adminis-
tration factoring in delirium episodes in patients
with advanced cancer (Centeno et al., 2004), opiate
administration factored into almost 90% of delirium
episodes within our sample. This may partially be
due to the particular population of medically ill can-
cer patients and frequent opiate administration in
this population. There were no differences evident
in opiate administration between the severely and
less severely medically ill.
Table 1. Sociodemographic and medical characteristics of patients with severe illness
Severe Illness (n ¼ 67) Less Severe Illness (n ¼ 44) Statistics
Age 65.9 (23–86, SD ¼ 13.4) 65.0 (23–89, SD ¼ 14.1) –0.326 (40), p ¼ 0.745a
Gender (in %) 0.09 (4), p ¼ 0.834b
Male 59.7 56.8
Female 40.3 43.2
Ethnicity (in %) 3.79 (4), p ¼ 0.486b
White 90.9 79.1





Lung 20.9 22.7 0.05 (1), p ¼ 1b
Brain 4.5 20.5 7.03 (1), p ¼ 0.012b
Gastrointestinal 31.3 11.4 5.91 (1), p ¼ 0.021b
Genitourinary 7.5 11.4 0.49 (1), p ¼ 0.514b
Sarcoma 6.0 9.1 0.39 (1), p ¼ 0.710b
Head and neck 6.0 6.8 0.03 (1), p ¼ 1b
Gynecological 11.9 4.5 1.77 (1), p ¼ 0.31b
Endocrine – 6,8 –
Lymphoma – 2.3 –
Skin 4.5 – –
Hematological 3.0 – –
Other 4.5 4.6 0.05 (1), p ¼ 1b




Brain metastasis (in %) 10.4 6.8 0.47 (1), p ¼ 0.737b
Etiologies (in %)
Opiates 88.1% 88.6% 0.01 (1), p ¼ 1b
Corticosteroids 37.3% 61.4% 6.17 (1), p ¼ 0.01b
Infection 34.3% 9.1% 9.19 (1), p , 0.001b
Hypoxia 44.8% 25.0% 4.46 (1), p ¼ 0.045b
Presence of CNS disease 10.4% 15.4% 0.72 (1), p ¼ 0.012b
Dehydration 6.0% 4.5% 0.11 (1), p ¼ 1b
Other medications 85.1% 84.1% 0.02 (1), p ¼ 1b
Sum of etiologies 5.0 (3–8, SD ¼ 9) 5.0 (3–7, SD ¼ 1.1) 1,458, p ¼ 0.906c
MDAS score total 18.8 (12–30, SD ¼ 4.4) 17.4 (11–28, SD ¼ 4.8) 1,200, p ¼ 0.099c
KPS score 19.7 (10–20, SD ¼ 1.7) 30.7 (30–40, SD ¼ 2.5) 2,278, p , 0.001c
MDAS ¼Memorial Delirium Assessment Scale; KPS ¼ Karnofsky Performance Status scale.
at test, bPearson’s chi-square test (x2), cMann–Whitney U test.
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Interestingly, gastrointestinal cancer was more of-
ten encountered in the severely ill and brain cancer
more often encountered in the less severely ill. In ad-
dition, gastrointestinal cancer was more frequently
advanced (73.1%) than brain cancer (8.3%), which
in context with more systemic illness might provide
a rationale for the higher prevalence in severe
illness.
Both age and previous history of dementia were
previously identified as risk factors for delirium (Lju-
bisavljevic & Kelly, 2003); however, they were not
demonstrated to affect severity of illness and were
not associated with severity of medical illness in
our sample.
These findings reproduced earlier results, such as
the association of hypoxia and infection as indicators
of illness severity and possible irreversibility of delir-
ium, in addition to providing new findings regarding
the quality of delirium in the severely medically ill
population. The level of disturbance in consciousness,
disorientation, and attentional impairmentweremore
severe and, in part,more frequent in the severelymed-
ically ill population. Both disorientation and inatten-
tion have been identified as more stable symptoms
over the course of delirium (Levkoff et al., 1994;
McCusker et al., 2003); however, the association of se-
verity of symptomswith severity ofmedical illness has
previously not been demonstrated.
Although our study has strengths, including the
prospective collection of data and the systematic
evaluation and documentation of delirium and con-
tributing etiologies, certain limitations have to be
noted. The design of our study was cross-sectional,
so that the evolution of symptoms over time in re-
spect to delirium severity could not be determined.
Longitudinal studies have suggested psychomotor
abnormalities, sleep–wake cycle disturbances in
the early course of delirium (Fann et al., 2005), diso-
rientation, inattention, impaired memory, and sleep
disturbances as the most persistent symptoms
through the course of delirium (Levkoff et al., 1994;
McCusker et al., 2003). Within our sample, patients
with cognitive deficits were not excluded. Brain me-
tastases were present in 24%, and 18% had a history
of dementia. However, excluding patients with cogni-
tive deficits from the sample did not alter our results.
This was not surprising, as dementia has not been
deemed to alter delirium phenomenology (Trzepacz
et al., 1998). The etiology of delirium in this sample
population of cancer patients was multifactorial
and included medications with psychotropic effects.
Furthermore, all subjects had cancer diagnoses,
and the generalizability of these results to the non-
cancer population may be limited. Further studies
are required to understand the impact of etiological
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In summary, delirium in the severely medically ill
cancer population may be characterized by an in-
creased disturbance of consciousness, disorientation,
and an inability to maintain and shift attention.
Severity of medical illness was not found to be associ-
ated with severity of delirium. The etiologies found to
be associated with delirium in severe medical illness
were hypoxia and infection.
CONFLICTS OF INTEREST
The authors state that they have no conflicts of inter-
est to declare.
REFERENCES
American Psychiatric Association (2000). Diagnostic and
statistical manual of mental disorders, 4th ed., Text
Revision (DSM–IV–TR). Washington, DC: American
Psychiatric Association (see esp. pp. 124–127).
Bond, S.M., Neelon, V.J. & Belyea, M.J. (2006). Delirium in
hospitalized older patients with cancer. Oncology Nurs-
ing Forum, 33, 1075–1083.
Breitbart, W. & Strout, D. (2000). Delirium in the terminal-
ly ill. Clinics in Geriatric Medicine, 16, 357–372.
Breitbart, W., Rosenfeld, B., Roth, A., et al. (1997). TheMe-
morial Delirium Assessment Scale. Journal of Pain and
Symptom Management, 13, 128–137.
Bucht, G., Gustafson, Y. & Sandberg, O. (1999). Epidemiol-
ogy of delirium. Dementia and Geriatric Cognitive
Disorders, 10, 315–318.
Centeno, C., Sanz, A. & Bruera, E. (2004). Delirium in
advanced cancer patients. Palliative Medicine, 18,
184–194.
Fann, J.R., Alfano, C.M., Burington, B.E., et al. (2005). Clin-
icalpresentationofdeliriuminpatientsundergoinghema-
topoietic stem cell transplantation.Cancer, 103, 810–820.
Francis, J., Martin, D. & Kapoor, W.N. (1990). A prospec-
tive study of delirium in hospitalized elderly. The Jour-
nal of the American Medical Association, 263,
1097–1101.
Gagnon, P., Allard, P., Masse, B., et al. (2000). Delirium in
terminal cancer: A prospective study using daily screen-
ing, early diagnosis, and continuous monitoring. Jour-
nal of Pain and Symptom Management, 19, 412–426.
Gaudreau, J.D., Gagnon, P., Harel, F., et al. (2005). Psycho-
active medications and risk of delirium in hospitalized
cancer patients. Journal of Clinical Oncology, 20(23),
6712–6718.
Inouye, S.K. (1998). Delirium in hospitalized older pa-
tients. Clinics in Geriatric Medicine, 14, 745–764.
Karnofsky, D.A. & Burchenal, J.H. (1949). The clinical
evaluation of chemotherapeutic agents in cancer. In
Evaluation of chemotherapeutic agents. C.M. Macleod
(ed.), pp. 191–205. New York: Columbia University
Press.
Lawlor, P.G., Gagnon, B., Mancini, I.L., et al. (2000a).
Occurrence, causes, and outcome of delirium in patients
with advanced cancer: A prospective study. Archives of
Internal Medicine, 160, 786–794.
Lawlor, P.G., Nekolaichuk, C., Gagnon, B., et al. (2000b).
Clinical utility, factor analysis, and further validation
of the memorial delirium assessment scale in patients
with advanced cancer: Assessing delirium in advanced
cancer. Cancer, 88, 2859–2867.
Levkoff, S.E., Liptzin, B., Evans, D.A., et al. (1994). Pro-
gression and resolution of delirium in elderly patients
hospitalized for acute care. The American Journal of
Geriatric Psychiatry, 2, 230–238.
Lipowski, Z.J. (1989). Delirium in the elderly patient. The
New England Journal of Medicine, 320, 578–582.
Ljubisavljevic, V. & Kelly, B. (2003). Risk factors for devel-
opment of delirium among oncology patients. General
Hospital Psychiatry, 25, 345–352.
Massie, M.J., Holland, J. & Glass, E. (1983). Delirium in
terminally ill cancer patients. The American Journal
of Psychiatry, 140, 1048–1050.
McCusker, J., Cole, M., Dendukuri, N., et al. (2003). The
course of delirium in older medical inpatients: A pro-
spective study. Journal of General Internal Medicine,
18, 696–704.
Trzepacz, P.T., Mulsant, B.H., Amanda, D.M., et al. (1998).
Is delirium different when it occurs in dementia? A
study using the delirium rating scale. The Journal of
Neuropsychiatry and Clinical Neurosciences, 10,
199–204.
Trzepacz, P.T., Breitbart, W., Franklin, J., et al. (1999).
Practice guidelines for the treatment of patients with
delirium of the American Psychiatric Association. The
American Journal of Psychiatry, 156, 1–20.
Voyer, P., McCusker, J., Cole, M.G., et al. (2007). Factors as-
sociated with delirium severity among older patients.
Journal of Clinical Nursing, 16, 819–831.
Boettger et al.1092
https://doi.org/10.1017/S1478951514001060
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 15:33:01, subject to the Cambridge Core terms of use, available at https:/www.cambridge.org/core/terms.
